Day: May 24, 2021

Seeking Referral of Patients with Non-dialysis-dependent CKD and Metabolic Acidosis

To Health Care Professionals: Tricida, Inc. is conducting a randomized, placebo-controlled, Phase 3 clinical research study (VALOR-CKD) of the investigational drug veverimer (TRC101) to evaluate its efficacy and safety in delaying chronic kidney disease (CKD) progression in patients with non-dialysis-dependent CKD and metabolic acidosis. Veverimer is an investigational, once-daily, orally administered, non-absorbed polymer drug that […]

Read More

Follow Us